Impact of fluid type on outcomes in patients with subarachnoid hemorrhage
Official title: Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage - a Multi-center Randomized Double-blind Clinical Trial
Run by Insel Gruppe AG, University Hospital Bern · NCT04043598 · Data updated 2026-11-12
This study tests whether using different types of IV fluids can improve recovery for patients who have had a subarachnoid hemorrhage.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 320 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 3 sites (Sankt Gallen, Canton of St. Gallen and 2 other locations) |
| Status | Recruiting |
| Started | May 24, 2022 |
| Main results expected | July 2027 |
| Study ends | December 2027 |
| Registry record updated | April 29, 2026 |
| Trial ID | NCT04043598 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adult patients diagnosed with non-traumatic subarachnoid hemorrhage.
✕Probably not a fit
Patients with major intra-cranial trauma or those who have limitations on therapy at admission may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effects of different types of intravenous fluids on patients who have suffered a subarachnoid hemorrhage. It specifically compares sodium-rich normal saline to sodium-depleted lactated Ringer's solution to determine which fluid leads to better clinical outcomes. The primary focus is on the occurrence of vasospasm, a serious complication, as well as other factors such as mortality, brain edema, and overall patient recovery. The study aims to provide insights into how fluid choice can influence recovery in critically ill patients.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols that enhance recovery and reduce complications for patients with subarachnoid hemorrhage.
How similar studies have gone: Previous studies have indicated that the type of infusion fluid can significantly affect sodium levels and patient outcomes, suggesting that this approach has merit.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: All adult patients suffering from non-traumatic subarachnoid haemorrhage. Exclusion Criteria: * Patients with major intra-cranial trauma * Diagnosis of an AV-malformation as the source of subarachnoid hemorrhage on the primary CT/MRI or angiography * More than 24 hours after diagnosis of subarachnoid haemorrhage as diagnosed by cerebral imaging (CT scan or MRI) * Patients with clear limitation to therapy at hospital admission (eg ICU admission for evaluation of organ donation) * Declining of informed consent
Where it's running
-
Department of perioperative Intensive Care Medicine
Sankt Gallen, Canton of St. Gallen, Switzerland Recruiting -
Department of Intensive Care, Bern University Hospital and University of Bern, Bern, Switzerland
Bern, Switzerland Recruiting -
Department of Intensive Care Medicine
Geneva, Switzerland Recruiting
Study contacts
- Principal investigator: Anna S Messmer, MD — Department of Intensive Care, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland
- Study coordinator: Anna S Messmer, MD
- Email: anna.messmer@insel.ch
- Phone: +41316322111
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Smartphone-based EEG to detect hidden awareness in ICU patients with brain injuries
Researchers will test a smartphone-enabled EEG to see if it can reveal Cognitive Motor Dissociation in ICU patients who can’t show commands at bedside.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
-
French validation of the SAHOT outcome tool after subarachnoid hemorrhage
This study tests whether a French version of the SAHOT questionnaire reliably measures outcomes in adults after subarachnoid hemorrhage.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.